A phase I trial of TPI-287 as a single agent and it combination with temozolomide in relapsed neuroblastoma or medulloblastoma

Saulnier Sholler G, Bergendahl G, Lenox S, Zage P, Roberts W, Kraveka J, Eslin D, Kaplan J, Higgins T, Ferguson T.  A phase I trial of TPI-287 as a single agent and it combination with temozolomide in relapsed neuroblastoma or medulloblastoma. June 2010 ASCO Annual Meeting, Chicago, IL